Colorblindness linked to higher risk of delayed bladder cancer detection
For many people, spotting blood in the urine is often the first warning sign of bladder cancer. But for those with color vision deficiency, commonly called colorblindness, that signal can easily go unnoticed. Now, a study from Stanford Medicine shows that missing this visual cue can have serious consequences for survival. Researchers analyzing health records found that people with bladder cancer who are also colorblind face a 52 percent higher risk of dying over 20 years than patients with normal vision. The findings suggest that delays in noticing blood in urine may lead to later-stage diagnoses and poorer outcomes. “I’m hopeful that this study raises some awareness, not only for patients with colorblindness, but for our colleagues who see these patients,” said Ehsan Rahimy, MD, adjunct clinical associate professor of ophthalmology and senior author of the study. Kaplan–Meier overall survival curve among cohorts with bladder cancer. (CREDIT: Nature) Understanding Color Vision Deficiency Color vision deficiency affects roughly 1 in 12 men and 1 in 200 women. The most common types make it difficult to distinguish …




